Clinical Trial

The Correction of Midface Volume Deficiency and/or Midface Contour Deficiency

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this clinical trial is to evaluate the efficacy and safety of PEGDE-crosslinked hyaluronic acid hydrogels for the correction of midface volume deficiency and/or midface contour deficiency, on the premise of ensuring the safety of the subjects and maintaining the scientific integrity of the clinical trial.
Trial Details
NCT Number NCT07359079
Lead Sponsor Chongqing Jinsaixing Medical Technology Co., Ltd
Conditions the Correction of Midface Volume Deficiency and/or Midface Contour Deficiency
Enrollment 356 participants
Start Date 2025-03-19
Primary Completion 2026-11-01 (estimated)
Study Completion 2027-02-27 (estimated)
Updated on ClinicalTrials.gov 2026-01-22